Pfizer

PFE Health Care Market cap $158B as of Sep 14, 2026 16:01 ET S&P 500

Q1 FY26 Jan 1 – Mar 29, 2026 reported May 5, 2026

Revenue$14.5B +5% year over year

Gross profit$10.9B 75% margin

Operating profit−$3.2B −22% margin

Net profit$2.7B 19% margin

Net profit is larger than what operations earned, because the statement adds $6.3B below it, under Other income, net.

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 29, 2026).
Item	Value	Share of revenue	Year over year
Revenue	14.5	100%	+5%
US	8.7	60%	+4%
Developed markets	3.4	24%	+8%
International emerging	2.3	16%	+6%
Cost of revenue	−3.5	25%
Gross profit	10.9	75% margin	−4pp
SG&A	−3.0	20%	−2pp
Other	−11.1	77%
Operating profit	−3.2	−22% margin	+0pp
Other income, net	6.3
Tax	−0.5
Net profit	2.7	19% margin	−3pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 28, 2025).
Item	Value	Share of revenue	Year over year
Revenue	16.7	100%	−6%
US	10.7	64%	−11%
Developed markets	3.7	22%	+8%
International emerging	2.3	14%	+2%
Cost of revenue	−4.2	25%
Gross profit	12.5	75% margin	+5pp
SG&A	−3.2	19%	+1pp
Other	−12.8	77%	+0pp
Operating profit	−3.6	−21% margin	+0pp
Tax benefit and other	7.1
Net profit	3.5	21% margin	−4pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 29, 2025).
Item	Value	Share of revenue	Year over year
Revenue	14.7	100%	+10%
US	8.9	61%	+13%
Developed markets	3.4	23%	+7%
International emerging	2.4	16%	+6%
Cost of revenue	−3.8	26%
Gross profit	10.9	74% margin	−1pp
SG&A	−3.4	23%	−5pp
Other	−10.5	72%	+0pp
Operating profit	−3.1	−21% margin	+0pp
Other income, net	6.1
Tax	−0.1
Net profit	2.9	20% margin	+20pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY25 (period ends Mar 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	13.7	100%	−8%
US	8.4	61%	−12%
Developed markets	3.2	23%	−1%
International emerging	2.2	16%	+0%
Cost of revenue	−2.8	21%
Gross profit	10.9	79% margin	+2pp
SG&A	−3.0	22%	−1pp
Other	−10.8	79%	+0pp
Operating profit	−3.0	−22% margin	+0pp
Tax benefit and other	5.9
Net profit	3.0	22% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q1 FY26 Jan 1 – Mar 29, 2026 reported May 5, 2026 Operating margin −22% Net profit $2.7B	Jan 1 – Mar 29, 2026	May 5, 2026	$14.5B	+5%	−22%	$2.7B	19%
Q3 FY25 Jun 30 – Sep 28, 2025 reported Nov 4, 2025 Operating margin −21% Net profit $3.5B	Jun 30 – Sep 28, 2025	Nov 4, 2025	$16.7B	−6%	−21%	$3.5B	21%
Q2 FY25 Mar 31 – Jun 29, 2025 reported Aug 5, 2025 Operating margin −21% Net profit $2.9B	Mar 31 – Jun 29, 2025	Aug 5, 2025	$14.7B	+10%	−21%	$2.9B	20%
Q1 FY25 Jan 1 – Mar 30, 2025 reported May 5, 2025 Operating margin −22% Net profit $3.0B	Jan 1 – Mar 30, 2025	May 5, 2025	$13.7B	−8%	−22%	$3.0B	22%